SEC Form 4 · accession 0001104659-18-014162
Voyager Therapeutics, Inc. · VYGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dinah Sah Ph.D.
Officer — Chief Scientific Officer
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2018 | M | 2,184 | $7.27 | D | 140,872 | D | |
| Common Stock | Feb 27, 2018 | M | 4,376 | $8.33 | D | 145,248 | D | |
| Common Stock | Feb 27, 2018 | M | 5,000 | $11.09 | D | 150,248 | D | |
| Common Stock | Feb 27, 2018 | M | 4,063 | $11.83 | D | 154,311 | D | |
| Common Stock | Feb 27, 2018 | S | 15,623 | $30.00 | D | 138,688 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $7.27 | Feb 27, 2018 | M | 2,184 | D | — | Apr 25, 2025 | Common Stock | 2,184 | 12,957 | D |
| Stock Option (Right to Buy)F3 | $8.33 | Feb 27, 2018 | M | 4,376 | D | — | Aug 25, 2025 | Common Stock | 4,376 | 28,570 | D |
| Stock Option (Right to Buy)F4 | $11.09 | Feb 27, 2018 | M | 5,000 | D | — | Feb 1, 2026 | Common Stock | 5,000 | 35,000 | D |
| Stock Option (Right to Buy)F5 | $11.83 | Feb 27, 2018 | M | 4,063 | D | — | Feb 8, 2027 | Common Stock | 4,063 | 60,937 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of January 1, 2015, and 1/48th of the shares underlying such option vesting monthly thereafter.
- F3The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of August 1, 2015, and 1/48th of the shares underlying such option vesting monthly thereafter. This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3.
- F4The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of February 1, 2016, and 1/48th of the shares underlying such option vesting monthly thereafter. This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3.
- F5The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of February 8, 2017, and 1/48th of the shares underlying such option vesting monthly thereafter. This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3.